450 related articles for article (PubMed ID: 8094033)
21. p53 alterations in chemically induced hamster cheek-pouch lesions.
Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
[TBL] [Abstract][Full Text] [Related]
22. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
[TBL] [Abstract][Full Text] [Related]
23. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
[TBL] [Abstract][Full Text] [Related]
24. [Correlation between p53 nuclear protein accumulation and mutations of the p53 gene in human esophageal cancer from linxian].
Liang Y; Lu S; Guo Y
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):412-4. PubMed ID: 8697989
[TBL] [Abstract][Full Text] [Related]
25. Frequent association of p53 gene mutation in invasive bladder cancer.
Fujimoto K; Yamada Y; Okajima E; Kakizoe T; Sasaki H; Sugimura T; Terada M
Cancer Res; 1992 Mar; 52(6):1393-8. PubMed ID: 1540947
[TBL] [Abstract][Full Text] [Related]
26. Detection of p53 gene mutations in human esophageal squamous cell carcinomas using a p53 yeast functional assay: possible difference in esophageal carcinogenesis between the young and the elderly group.
Okuda E; Osugi H; Morimura K; Takada N; Takemura M; Fukushima S; Higashino M; Kinoshita H
Clin Cancer Res; 2001 Mar; 7(3):600-6. PubMed ID: 11297255
[TBL] [Abstract][Full Text] [Related]
27. Expression of p53 and 17p allelic loss in colorectal carcinoma.
Cunningham J; Lust JA; Schaid DJ; Bren GD; Carpenter HA; Rizza E; Kovach JS; Thibodeau SN
Cancer Res; 1992 Apr; 52(7):1974-80. PubMed ID: 1551126
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
[TBL] [Abstract][Full Text] [Related]
29. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.
Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P
J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886
[TBL] [Abstract][Full Text] [Related]
30. [Correlation between p53 gene mutation and protein expression in 30 cases of human lung cancer].
Zhang J; Zheng J; Fang W
Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):846-9. PubMed ID: 11038779
[TBL] [Abstract][Full Text] [Related]
31. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
[TBL] [Abstract][Full Text] [Related]
32. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer.
Okamoto A; Sameshima Y; Yokoyama S; Terashima Y; Sugimura T; Terada M; Yokota J
Cancer Res; 1991 Oct; 51(19):5171-6. PubMed ID: 1680546
[TBL] [Abstract][Full Text] [Related]
33. An uncertain role for p53 gene alterations in human prostate cancers.
Brooks JD; Bova GS; Ewing CM; Piantadosi S; Carter BS; Robinson JC; Epstein JI; Isaacs WB
Cancer Res; 1996 Aug; 56(16):3814-22. PubMed ID: 8706029
[TBL] [Abstract][Full Text] [Related]
34. Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas.
Campo E; de la Calle-Martin O; Miquel R; Palacin A; Romero M; Fabregat V; Vives J; Cardesa A; Yague J
Cancer Res; 1991 Aug; 51(16):4436-42. PubMed ID: 1868464
[TBL] [Abstract][Full Text] [Related]
35. p53 Gene mutation and genetic instability in superficial multifocal esophageal squamous cell carcinoma.
Fujiki T; Haraoka S; Yoshioka S; Ohshima K; Iwashita A; Kikuchi M
Int J Oncol; 2002 Apr; 20(4):669-79. PubMed ID: 11894109
[TBL] [Abstract][Full Text] [Related]
36. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M
Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785
[TBL] [Abstract][Full Text] [Related]
37. Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers.
Kropveld A; Rozemuller EH; Leppers FG; Scheidel KC; de Weger RA; Koole R; Hordijk GJ; Slootweg PJ; Tilanus MG
Lab Invest; 1999 Mar; 79(3):347-53. PubMed ID: 10092071
[TBL] [Abstract][Full Text] [Related]
38. Accumulation of p53 in esophageal squamous cell carcinoma.
Chino O; Kijima H; Shimada H; Nishi T; Tanaka H; Kise Y; Kenmochi T; Himeno S; Machimura T; Tanaka M; Inokuchi S; Tajima T; Osamura RY; Makuuchi H
Int J Mol Med; 2001 Oct; 8(4):359-63. PubMed ID: 11562772
[TBL] [Abstract][Full Text] [Related]
39. Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma.
Bradley G; Irish J; MacMillan C; Mancer K; Witterick I; Hartwick W; Gullane P; Kamel-Reid S; Benchimol S
Oncogene; 2001 Feb; 20(5):654-8. PubMed ID: 11313998
[TBL] [Abstract][Full Text] [Related]
40. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.
Makino T; Yamasaki M; Miyata H; Yoshioka S; Takiguchi S; Fujiwara Y; Nakajima K; Nishida T; Mori M; Doki Y
Ann Surg Oncol; 2010 Mar; 17(3):804-11. PubMed ID: 19885698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]